447 related articles for article (PubMed ID: 9630355)
41. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
Jones S; Evans RJ; Mahaut-Smith MP
Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
[TBL] [Abstract][Full Text] [Related]
42. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
Ecke D; Hanck T; Tulapurkar ME; Schäfer R; Kassack M; Stricker R; Reiser G
Biochem J; 2008 Jan; 409(1):107-16. PubMed ID: 17824841
[TBL] [Abstract][Full Text] [Related]
43. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
[TBL] [Abstract][Full Text] [Related]
44. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Bambace NM; Levis JE; Holmes CE
Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
[TBL] [Abstract][Full Text] [Related]
45. Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
King BF; Wildman SS; Ziganshina LE; Pintor J; Burnstock G
Br J Pharmacol; 1997 Aug; 121(7):1445-53. PubMed ID: 9257926
[TBL] [Abstract][Full Text] [Related]
46. Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
Kobsar AL; Koessler J; Rajkovic MS; Brunner KP; Steigerwald U; Walter U
Platelets; 2010; 21(2):112-6. PubMed ID: 20085435
[TBL] [Abstract][Full Text] [Related]
47. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
48. Calmodulin interacts with the platelet ADP receptor P2Y1.
Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
[TBL] [Abstract][Full Text] [Related]
49. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
50. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
[TBL] [Abstract][Full Text] [Related]
51. A chimeric rat brain P2Y1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor.
Vöhringer C; Schäfer R; Reiser G
Biochem Pharmacol; 2000 Apr; 59(7):791-800. PubMed ID: 10718337
[TBL] [Abstract][Full Text] [Related]
52. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
[TBL] [Abstract][Full Text] [Related]
53. No requirement of P2X1 purinoceptors for platelet aggregation.
Takano S; Kimura J; Matsuoka I; Ono T
Eur J Pharmacol; 1999 May; 372(3):305-9. PubMed ID: 10395026
[TBL] [Abstract][Full Text] [Related]
54. Stimulation of P2U purinergic or alpha 1A adrenergic receptors mobilizes Ca2+ in lens cells.
Churchill GC; Louis CF
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):855-65. PubMed ID: 9112981
[TBL] [Abstract][Full Text] [Related]
55. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
56. Differential sensitivity of human platelet P2X1 and P2Y1 receptors to disruption of lipid rafts.
Vial C; Fung CY; Goodall AH; Mahaut-Smith MP; Evans RJ
Biochem Biophys Res Commun; 2006 May; 343(2):415-9. PubMed ID: 16546137
[TBL] [Abstract][Full Text] [Related]
57. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
58. [Efficacy of purine nucleotides on purinergic P2 platelet receptors by small angle light scattering].
Sakaev MR; Mindukshev IV; Lesiovskaia EE; Petrishchev NN; Krivchenko AI
Eksp Klin Farmakol; 2000; 63(3):65-9. PubMed ID: 10934601
[TBL] [Abstract][Full Text] [Related]
59. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
Park HS; Hourani SM
Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
